Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models

  • Folashade Otegbeye,
  • Evelyn Ojo,
  • Stephen Moreton,
  • Nathan Mackowski,
  • Dean A. Lee,
  • Marcos de Lima,
  • David N. Wald

The first two authors, Folashade Otegbeye and Evelyn Ojo, should be noted as contributing equally to this work.

The following information is missing from the Funding section: This study was supported by NIH grant T32 GM007250 to EO.

Reference

  1. 1. Otegbeye F, Ojo E, Moreton S, Mackowski N, Lee DA, de Lima M, et al. (2018) Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models. PLoS ONE 13(1): e0191358. https://doi.org/10.1371/journal.pone.0191358 pmid:29342200

Citation: Otegbeye F, Ojo E, Moreton S, Mackowski N, Lee DA, de Lima M, et al. (2018) Correction: Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models. PLoS ONE 13(5): e0197008. https://doi.org/10.1371/journal.pone.0197008

Published: May 2, 2018

Copyright: © 2018 Otegbeye et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.